Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

#18-104 Listing of Mini futures issued by Vontobel Financial Products GmbH

As from January 22, 2018, 3 Mini futures issued by Vontobel Financial Products GmbH will be listed on ETP Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB.Issuer: Vontobel Financial Products GmbH Type of security: Mini futures, open ended Execution: Automatic cash settlement Term: As from January 22, 2018 and forward or until time for knock out event Market Maker: Bank Vontobel Europe AG Underlying: Vestas Wind Systems A/S Silver (troy ounce) Gold (troy ounce) Current values of strike and barrier can

Young, innovative Swedish startup finds a partner in Paulig: Mode gains additional strength for product development, internationalisation and growth

Paulig has obtained a majority holding in the Swedish coffee company Mode Cold Brew. With the investment, Paulig strengthens its position in Sweden and expands its product selection with the unique cold brew coffee. Mode Cold Brew coffee, which is completely free of additives and sugar, has been served at events such as the Nobel banquet after-party, and its owners include the musician Avicii.Paulig is keen to be at the forefront of food industry development and learn from startup companies. Partnerships are a part of Paulig’s strategy, which enables the more than 140-year-old family-owned

Redwood Pharma to Attend BIO-Europe 2018, Mar. 11 – 14 in Amsterdam for Partnering Discussions

Redwood Pharma will be attending BIO-Europe 2018 in Amsterdam, Mar. 11 - 14 to meet and continue discussions with potential pharmaceutical partners regarding co-development and licensing of RP101, the Company’s therapy to treat chronic dry eye disease in postmenopausal women and the IntelliGel drug delivery platform.RP101 is the Company’s lead program for the development of a novel treatment of chronic dry eye disease in postmenopausal women. The active substance is an endogenous small molecule already proven safe and effective in two Phase II clinical trials conducted in the US. The active

FONDIA ACQUIRES A SWEDISH FORERUNNER IN THE LEGAL SECTOR

The largest non-bar law firm in the Nordic region, Fondia Plc, will acquire the entire share capital of the Swedish law firm Jansson & Norin AB (J&N) in order to boost its growth and strengthen its position on the Swedish market. With operations started in 2012, J&N is a successful growth company and like Fondia, is renowned for its innovative business models and business culture. According to preliminary data, J&N's turnover for the year 2017 was EUR 1.4 million and operating profit EUR -0.1 million. The negative result is caused by a one-off adjustment in the accounting for personnel

Obducat receives order for a fully automated wet processing system

OBDUCAT AB (publ) subsidiary Obducat Europe GmbH, a leading supplier of system solutions for lithography processing, has received an order from a leading semiconductor manufacturer, for the supply of a MC 208 (fully automated resist coating and developing system). The order value amounts to approx. 760 k€.The MC 208 system will be installed in the customers cleanroom production facilities. The customer target with the investment is to bring their production facilities to higher automation level as well as to increase production capacity. The MC 208 system is planned to be delivered end

UPM Biofuels and ZERO environmental organisation cooperate to promote green shift in transportation and petrochemical industry

(UPM, Helsinki, 22 January 2018 at 11:00 EET) - UPM Biofuels and the Zero Emission Resource Organisation have started cooperation in promoting green shift in the transport and petrochemicals sectors. The work focuses on creating a predictable long term operating environment for sustainable, advanced biofuels  to enable climate change mitigation in transport with renewable fuels. The cooperation also aims to enhance knowledge of sustainable fossil-free bioproducts, such as bioplastics, as an important climate solution for example in the packaging and labelling industries. The work is

First order in Kazakhstan strengthens Vestas’ global reach

Underlining Vestas’ ability to deliver competitive wind energy solutions in all parts of the world, Central Asian power-energy company CAPEC Green Energy LLP, a main player on Kazakhstan’s renewable energy market, has ordered 52 MW of V112-3.45 MW turbines for the Astana wind project. The turbines will be delivered in both 3.3 MW load optimised mode and standard 3.45 MW rating. Once installed, the project will add another market to Vestas’ global footprint, which currently spans across 76 markets. “We have chosen to work with Vestas because their technology combines performance with

Follicum appoints a Project Manager for the company's diabetes project

Follicum has recruited Susanne Scheele to the position of Project Manager for the company's diabetes project. Susanne will commence her new role in January 2018.Susanne Scheele has extensive experience from both the pharmaceutical industry and academic research institutions including Lund and Uppsala Universities. Her previous positions include that of Senior Scientist at Novo Nordisk A/S in Denmark, where she worked on the development of oral GLP-1 analogues in the field of diabetes. Susanne holds a PhD in Medical Sciences from Lund University. At Follicum, Susanne will be responsible for

Change in number of shares in Brighter AB.

Conversion of convertible notes into shares under the Convertible Notes issued under the financing agreement announced on April 26. Change in handling of information regarding the L1 Capital financing.  Brighter will in future transactions within the present agreement with L1 Capital, not send any press releases. Current information will instead be published on the website under the following link.  https://brighter.se/en/investors/financing-through-l1-capital/ The number of Notes converted on January 19th, 2018 was 18. The number of Notes remaining under the fourth Tranche for future

Publishing of Caverion Corporation's Financial Statement Release for 2017 on 7 February 2018

Caverion Corporation Investor News 22 January 2018 at 10.00 a.m. EETPublishing of Caverion Corporation's Financial Statement Release for 2017 on 7 February 2018 Caverion Corporation's Financial Statement Release for 2017 will be published on Wednesday, 7 February 2018, at 8:00 a.m. (Finnish Time, EET). The stock exchange release and presentation materials in Finnish and in English will be published at that time on the company's website at www.caverion.com/investors. News conference for investors and media  Caverion will hold a news conference on the Financial Statement Release on

Catella: Positive outlook for German real estate markets in 2018

Rising rents, falling vacancy rates, residential climbing to third-strongest asset class, retail under pressure.The latest overview of the 2018 German rental and investment markets from Catella Research shows that the economic situation is supporting the positive trend.The nation is in a very good position economically, with a recent correction of the GDP growth forecast to 2.2% by 2019. The boom is becoming more dynamic due to very good consumer conditions and higher exports rates. Expected wage agreements in the coming quarters lead us to believe that the consumption rate in Germany

WORLD MARKET LEADER IN MOBILE SANITARY SYSTEMS, THETFORD, SELECTS IFS APPLICATIONS IN THE CLOUD TO SUPPORT RAPID GROWTH

IFS Applications deployed on Microsoft Azure to support Production, Finance, HR and Supply Chain management at Thetford IFS , the global enterprise applications company, today announced that market leader in mobile sanitary systems Thetford, based in Etten-Leur, The Netherlands, has selected IFS Applications™  as its core solution to manage its European production facilities in the Netherlands, USA, UK and Italy. The IFS solution includes Finance, HR, and Supply Chain to support Thetford’s planned

Restamax Plc: RESTAMAX RENEWS ITS ORGANISATION AND RESTRUCTURES ITS EXECUTIVE TEAM

Restamax PlcSTOCK EXCHANGE RELEASE 22 January 2018, 9:59RESTAMAX RENEWS ITS ORGANISATION AND RESTRUCTURES ITS EXECUTIVE TEAMRestamax Plc renews its organisation structure and the composition of its Executive Team in line with its strategy. In future, Restamax's operational organisation shall be divided into three business units: Nightclubs, Food restaurants and Pubs&Entertainment.The Nightclubs and Pubs&Entertainment business units will be headed by Paul Meli. The Food restaurants unit will be run by Tero Kaikkonen.The role of sales and marketing will be strengthened further in

Norwegian real estate company relies on Swedish Fin Tech

It’s not just financials companies that need financial technology. Real estate companies, too, handle large sums of money. That’s why Norwegian real estate developer MIRIS becomes one of the increasing number if firms that benefit from Swedish Fin Tech pioneer Bricknode’s financial ecosystem.Large real estate development projects means big money are in circulation. Many companies bring in external investors by selling bonds or shares in the development project. Hence they need to keep track of things like share ownership, dividends and various taxes. One such company is Norwegian real

TetraGraph Poster and Abstract presentation at The Society for Technology in Anesthesia (STA) 2018

News; Uppsala, January 19, 2018. The STA 2018 Annual Meeting in Turnberry Isle Miami Aventura, Florida, January 10-13, is designated for a national and international audience of physicians, engineers and industry members, as well as other practitioners in the field of anesthesia seeking an update on the current and future state of anesthesia technology. https://www.stahq.org/events/annual-meeting During the meeting, Reka Nemes, MD, Mayo Clinic, Jacksonville, Florida presented an abstract and poster entitled, “Comparison of electromyography derived train-of-four ratios of the

Initiator Pharma successfully completes the preclinical development of its Erectile Dysfunction drug candidate IPED2015 ahead of time

PRESS RELEASE January 22, 2018 Initiator Pharma, a Biotech Company developing a novel treatment of Erectile Dysfunction (ED), has successfully completed the preclinical development of its drug candidate IPED2015. The studies were concluded ahead of the previously announced schedule and included experimental work with most of the recent positive data from the cardiovascular telemetry study, the respiratory study and a clean genotoxicity profile.“With the positive results from the final studies in genotoxicology and safety pharmacology of the preclinical development of IPED2015 we have

H&D Wireless receives first strategic order on SPB228 WLAN

H&D Wireless, Swedish leading supplier of IoT connectivity and IoT Cloud and RTLS Platform solutions, receives first purchase order of the new SPB228 WLAN and Bluetooth Combo module. The small, but strategically important order concerns two – so far secret – projects in Germany that will start immediately in Q1 2018.The SPB228, is the latest addition to the Accelerate© module family, recently launched at CES in Las Vegas . The order is aimed for the German customer's two products that are to be displayed on Embedded World 

Studsvik signs a strategic agreement for delivery of isotopes

The agreement means that Studsvik provides isotopes for application in products that will be sold globally. The isotopes are packaged in special containers at Studsvik's Hot Cell Laboratories in compliance with all current requirements. The agreement runs from now until 2026 and comprises deliveries to a value of a few hundred million SEK. Deliveries are scheduled from the end of 2018 and with full volume from 2022.Studsvik has a long history of supplying isotopes from when the research reactor was in operation and now resumes operations in this area. Studsvik will use its recognized

ISR Immune System Regulation Holding AB starts two new programs against TBC and cancer

Based on the concept of stimulating the immune system, ISR is currently developing a second line of immune-activating chemical entities together with the Cambridge based company Isomerase. The studies in the new indications will focus on TBC and cancer. Many bacteria and tumours have developed systems that help them avoid recognition and activation of the immune system. Therefore, there is a big and increasing medical need for immune stimulatory drugs. ISR-50, our IP protected lead drug candidate has enhanced immune stimulatory properties currently explored in vitro and in animal models

Receipt of payments for KRI oil exports

22 January 2018 Genel Energy plc Receipt of payments for KRI oil exports from the Tawke PSC Genel Energy plc ('Genel' or 'the Company') notes the announcement from DNO ASA, as operator of the Tawke PSC, that the Tawke partners have received $53.71 million from the Kurdistan Regional Government as payment towards October 2017 crude oil deliveries to the export market from the Tawke licence. Genel's net share of the payment is $13.43 million. The override payment relating to October 2017 exports from the Tawke PSC has already been received. Going forward, the Company and the KRG

Hat-trick for LeoVegas at EGR Nordics Awards 2018

The most successful and innovative gaming companies are noticed at the EGR Nordic Awards. In fierce competition, LeoVegas won three awards, "Nordics Operator of the Year", "Casino Operator of the Year" and "Sports Betting Operator of the Year". "We are extremely pleased to have won the Casino Operator and the Sports Betting Operator awards as these are the two main categories that define our product. Being declared as the Nordics Operator of the Year is really outstanding! To receive these awards is a receipt that we are an extremely talented team at LeoVegas that is constantly

The Nomination Committee proposes that Jan Ståhlberg is elected new member of the Board and Chairman of Bactiguard Holding AB (publ)

The Nomination Committee of Bactiguard Holding AB (publ) (Bactiguard) proposes that the Annual General Meeting 2018 elects Jan Ståhlberg as new member and Chairman of the Board, as Stanley Brodén who has been the Chairman of the Board since 2015 has declined reelection.Jan Ståhlberg is Vice Chairman of EQT AB and has been active in EQT since 1995. Earlier in his career, between 1985 and 1994, Jan Ståhlberg worked in various positions at Ovako Steel. Jan Ståhlberg has extensive experience in board work, both domestically and internationally, including the cancer diagnostic company Dako,

PUBLICATION HIGHLIGHTS A NOVEL CERAMENT® CARRIER WITH BONE ACTIVE AGENTS ENHANCING BONE FORMATION

Lund, Sweden, 08.00 CET, 22 January 2018 – BONESUPPORT™, an emerging leader in innovative injectable bio-ceramic bone substitute products to treat bone voids caused by trauma, infection, disease or related surgery based on its unique platform  announces that a paper “Gelatin- hydroxyapatite-calcium sulphate based biomaterial for long term sustained delivery of bone morphogenic protein-2 and zoledronic acid for increased bone formation: In-vitro and in-vivo carrier properties, - D Raina et al 2018- has been published online in the Journal of Controlled Release. The paper* can be viewed

The Nomination Committee’s recommendations for the Board of Humana AB

Prior to the 2018 AGM, Humana’s Nomination Committee, representing approx. 59 percent of the votes in the Company, recommends to the Annual General Meeting in 2018, that the existing Board of Directors in Humana is to be re-elected without any changes in the composition of the Board.Prior to the Annual General Meeting on May 16, 2018, the Nomination Committee of Humana AB recommends that the Board of Directors of Humana AB is to be re-elected without any changes to the composition of the Board. The Nomination Committee's decision is based on the significant changes that were implemented in

There are no items matching the current filter
There are no more items matching the current filter
Back to top